{"id":207555,"date":"2022-12-23T00:14:09","date_gmt":"2022-12-22T18:44:09","guid":{"rendered":"https:\/\/arunachaltimes.in\/?p=207555"},"modified":"2022-12-23T00:14:09","modified_gmt":"2022-12-22T18:44:09","slug":"sii-seeks-drug-regulators-approval-for-market-authorisation-of-its-covid-vaccine-as-booster-dose","status":"publish","type":"post","link":"https:\/\/arunachaltimes.in\/index.php\/2022\/12\/23\/sii-seeks-drug-regulators-approval-for-market-authorisation-of-its-covid-vaccine-as-booster-dose\/","title":{"rendered":"SII seeks drug regulator&#8217;s approval for market  authorisation of its Covid vaccine as booster dose"},"content":{"rendered":"<p style=\"text-align: justify;\">NEW DELHI, 22 Dec: The Serum Institute of India (SII) has sought the drug regulator&#8217;s approval for market authorisation of its Covid-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday.<br \/>\nPrakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for the heterologous booster dose of Covovax to the Drugs Controller General of India (DCGI) on 17 October.<br \/>\nIt has been learnt that the DCGI&#8217;s office had raised a few queries, after which Singh submitted a reply, mentioning about the current emerging situation caused by a new coronavirus variant.<br \/>\nCovovax was approved by the DCGI for a restricted emergency use in children aged seven to 11 years in June.<br \/>\nThe DCGI had approved Covovax for a restricted use in emergency situations in adults on 28 December, 2021 and for those in the 12-17 age group, subject to certain conditions, on 9 March.<br \/>\nCovovax is manufactured through technology transfer from Novavax. It has been approved by the European Medicines Agency for conditional marketing authorisation.<br \/>\nIt was granted emergency-use listing by the World Health Organisation (WHO) in December 2020. In August 2020, US-based vaccine maker Novavax Inc had announced a licence agreement with the SII for the development and commercialisation of NVX-CoV2373, its Covid-19 vaccine candidate, in India and low-and-middle-income countries. (PTI)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW DELHI, 22 Dec: The Serum Institute of India (SII) has sought the drug regulator&#8217;s approval for market authorisation of its Covid-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":{"0":"post-207555","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-national"},"_links":{"self":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/posts\/207555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/comments?post=207555"}],"version-history":[{"count":0,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/posts\/207555\/revisions"}],"wp:attachment":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/media?parent=207555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/categories?post=207555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/tags?post=207555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}